(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE
Diverticulitis
Des Moines UniversitySmall moleculePhase 4 / ApprovedDormant
BBB
72/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 57/ 100
- Competitive Position
- 95/ 100
Competitive context
0 Active assets in the Diverticulitis cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Hextend Corewell Health West | Phase 3 | BB |
LIDOCAINE Franco Carli | Phase 2 | B |
NEPENTHE McGill University Health Centre/Research Institute of the McGill University Health Centre | Phase 1/2 | CCC |
MACROGOLS Thomas Jefferson University | Early Phase 1 | C |
METRONIDAZOLE Thomas Jefferson University | Early Phase 1 | C |
NEOMYCIN Thomas Jefferson University | Early Phase 1 | C |
CAFFEINE Thomas Steffen | N/A | D |
Same molecule, other indications
(±)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →